267 related articles for article (PubMed ID: 32885562)
1. Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy.
Meeks SL; Lacroix-Desmazes S
Haemophilia; 2020 Nov; 26(6):958-965. PubMed ID: 32885562
[TBL] [Abstract][Full Text] [Related]
2. Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis.
Carcao M; Shapiro A; Staber JM; Hwang N; Druzgal C; Lieuw K; Belletrutti M; Thornburg CD; Ahuja SP; Morales-Arias J; Dumont J; Miyasato G; Tsao E; Jain N; Pipe SW
Haemophilia; 2018 Mar; 24(2):245-252. PubMed ID: 29436077
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIII Fc fusion protein drives regulatory macrophage polarization.
Kis-Toth K; Rajani GM; Simpson A; Henry KL; Dumont J; Peters RT; Salas J; Loh C
Blood Adv; 2018 Nov; 2(21):2904-2916. PubMed ID: 30396910
[TBL] [Abstract][Full Text] [Related]
4. rFVIIIFC for hemophilia A prophylaxis.
Mahlangu J
Expert Rev Hematol; 2018 Dec; 11(12):937-943. PubMed ID: 30449223
[No Abstract] [Full Text] [Related]
5. Factor VIII-Fc Activates Natural Killer Cells
Lagassé HAD; Hopkins LB; Jankowski W; Jacquemin MG; Sauna ZE; Golding B
Front Immunol; 2021; 12():692157. PubMed ID: 34262568
[TBL] [Abstract][Full Text] [Related]
6. Recombinant factor VIII Fc for the treatment of haemophilia A.
Hermans C; Mancuso ME; Nolan B; Pasi KJ
Eur J Haematol; 2021 Jun; 106(6):745-761. PubMed ID: 33650192
[TBL] [Abstract][Full Text] [Related]
7. Indirect comparisons of efficacy and weekly factor consumption during continuous prophylaxis with recombinant factor VIII Fc fusion protein and conventional recombinant factor VIII products.
Iorio A; Krishnan S; Myrén KJ; Lethagen S; McCormick N; Yermakov S; Karner P
Haemophilia; 2017 May; 23(3):408-416. PubMed ID: 28233383
[TBL] [Abstract][Full Text] [Related]
8. [Switching toward the use of recombinant factor VIII Fc fusion protein Study among 30 patients with severe hemophilia A].
Sattler L; Raissi A; Fornoff D; Gérout AC; Feugeas O; Grunebaum L; Desprez D
Ann Biol Clin (Paris); 2020 Feb; 78(1):35-46. PubMed ID: 32108578
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study.
Nolan B; Mahlangu J; Pabinger I; Young G; Konkle BA; Barnes C; Nogami K; Santagostino E; Pasi KJ; Khoo L; Winding B; Yuan H; Fruebis J; Rudin D; Oldenburg J
Haemophilia; 2020 May; 26(3):494-502. PubMed ID: 32227570
[TBL] [Abstract][Full Text] [Related]
10. Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective.
Lorenzoni V; Triulzi I; Turchetti G
BMC Health Serv Res; 2018 Aug; 18(1):596. PubMed ID: 30071878
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden.
Henry N; Jovanović J; Schlueter M; Kritikou P; Wilson K; Myrén KJ
J Med Econ; 2018 Apr; 21(4):318-325. PubMed ID: 29139314
[TBL] [Abstract][Full Text] [Related]
12. Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein.
Oldenburg J; Kulkarni R; Srivastava A; Mahlangu JN; Blanchette VS; Tsao E; Winding B; Dumont J; Jain N
Haemophilia; 2018 Jan; 24(1):77-84. PubMed ID: 29082639
[TBL] [Abstract][Full Text] [Related]
13. Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.
Powell JS; Josephson NC; Quon D; Ragni MV; Cheng G; Li E; Jiang H; Li L; Dumont JA; Goyal J; Zhang X; Sommer J; McCue J; Barbetti M; Luk A; Pierce GF
Blood; 2012 Mar; 119(13):3031-7. PubMed ID: 22223821
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein.
Peters RT; Toby G; Lu Q; Liu T; Kulman JD; Low SC; Bitonti AJ; Pierce GF
J Thromb Haemost; 2013 Jan; 11(1):132-41. PubMed ID: 23205847
[TBL] [Abstract][Full Text] [Related]
15. The structural basis for the functional comparability of factor VIII and the long-acting variant recombinant factor VIII Fc fusion protein.
Leksa NC; Chiu PL; Bou-Assaf GM; Quan C; Liu Z; Goodman AB; Chambers MG; Tsutakawa SE; Hammel M; Peters RT; Walz T; Kulman JD
J Thromb Haemost; 2017 Jun; 15(6):1167-1179. PubMed ID: 28397397
[TBL] [Abstract][Full Text] [Related]
16. Predicting the outcomes of using longer-acting prophylactic factor VIII to treat people with severe hemophilia A: a hypothetical decision analysis.
Miners AH; Krishnan S; Pasi KJ
J Thromb Haemost; 2016 Nov; 14(11):2141-2147. PubMed ID: 27510890
[TBL] [Abstract][Full Text] [Related]
17. Comparison of one-stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII-Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single-centre, real-world experience of surgery.
Désage S; Nougier C; Meunier S; Chamouard V; Jousselme E; Dargaud Y; Lienhart A
Haemophilia; 2024 Mar; 30(2):538-544. PubMed ID: 38149726
[TBL] [Abstract][Full Text] [Related]
18. Efmoroctocog Alfa: A Review in Haemophilia A.
Frampton JE
Drugs; 2016 Sep; 76(13):1281-1291. PubMed ID: 27487799
[TBL] [Abstract][Full Text] [Related]
19. Real-world evidence on efmoroctocog alfa in patients with haemophilia A: A systematic literature review of treatment experience in Europe.
Blatný J; Nielsen EM; Reitzel SB; McMillan AC; Danø A; Bystrická L; Kragh N; Klamroth R
Haemophilia; 2023 Jul; 29(4):963-974. PubMed ID: 37243934
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice.
Krishnamoorthy S; Liu T; Drager D; Patarroyo-White S; Chhabra ES; Peters R; Josephson N; Lillicrap D; Blumberg RS; Pierce GF; Jiang H
Cell Immunol; 2016 Mar; 301():30-9. PubMed ID: 26775174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
